Gastrointestinal (GI) side-effects of chemotherapy are a debilitating and often overlooked
clinical hurdle in cancer management. Chemotherapy-induced constipation (CIC) and …

We know the susceptibility of patients with different cancers to malnutrition, albeit that there
are not widespread demographics. While cancer statistics are reported in most jurisdictions …

Malnutrition and muscle wasting are frequently reported in cancer patients, either linked to
the tumor itself or caused by oncologic therapies. Understanding the value of nutritional care …

Malnutrition is a frequent problem in cancer patients, which leads to prolonged and repeated
hospitalizations, increased treatment-related toxicity, reduced response to cancer treatment …

Intestinal microbiota mediate toxicity of irinotecan (CPT-11) cancer therapies and cause
systemic infection after CPT-11-induced loss of barrier function. The intestinal microbiota …

Cancer cachexia is a multi-organ syndrome with unintentional weight loss, sarcopenia, and
systemic inflammation. Gastrointestinal (GI) cancer patients are more susceptible to …

Chemotherapy for cancer patients induces damaging tissue reactions along the epithelium
of the gastrointestinal tract (GIT). This chemotherapy-induced mucositis (CIM) is a serious …

The intestinal microbiome encodes vast metabolic potential, and multidisciplinary
approaches are enabling a mechanistic understanding of how bacterial enzymes impact the …

Cachexia is a relevant comorbid condition of chronic diseases including cancer.
Inflammation, oxidative stress, autophagy, ubiquitin–proteasome system, nuclear factor (NF) …

It has become clear in recent years that the human intestinal microbiota plays an important
role in maintaining health and thus is an attractive target for clinical interventions. Scientists …